Business
Australia to consider EU and UK findings over AstraZeneca Covid vaccine and blood clots – The Guardian
Review follows a UK decision to offer people under 30 an alternative jab following formal link to rare blood clots
Vaccines and immunisation
Australian authorities will review the findings of British and European regulators over concerns about the AstraZeneca Covid-19 vaccine but continue to emphasise that the benefits outweigh the risks.
The review follows a decision in the United Kingdom to offer healthy adults aged under 30 an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.
The European Medicines Agency also announced on Wednesday that the rare blood clots would be listed…
-
Noosa News20 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General21 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General15 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General14 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues